No Data
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Haisco Pharmaceutical Group (002653.SZ) proposes a profit distribution plan for the first three quarters of 2024: a distribution of 1.35 yuan for every 10 shares.
On December 30, Gelonghui reported that Haisco Pharmaceutical Group (002653.SZ) announced the profit distribution plan for the first three quarters of 2024: it intends to distribute a cash dividend of 1.35 yuan (including tax) for every 10 shares based on the existing total share capital of 1,119,917,970 shares, totaling a cash dividend of 0.151 billion yuan.
US Morning News Call | Boeing Drops in Premarket as South Korea Orders Inspection of B737-800 Aircraft
Haisco Pharmaceutical Group (002653.SZ): A subsidiary has received acceptance notifications for two new indication IND applications for the innovative drug HSK44459 tablets.
On December 30th, Gelonghui reported that Haisco Pharmaceutical Group (002653.SZ) announced that its subsidiary Shanghai Haisco Shennuo Pharmaceutical Technology Co., Ltd. recently received the "Acceptance Notification" for HSK44459 tablets issued by the National Medical Products Administration. HSK44459 tablets are a brand new drug independently developed by the company with independent intellectual property rights for the treatment of psoriasis and atopic dermatitis. According to the National Medical Products Administration's announcement on the classification and application requirements for Chemical Drug registration (2020 No. 44), this product falls under Chemical Drug Class 1. Preclinical
Intel (INTC.US) is leading the wave of layoffs in Technology, contrary to the trends in the Industry.
Intel (INTC.US) has laid off approximately 0.015 million people this year, making it the leader in layoffs in the Technology Industry.
Will the "Fateful Eight" Stocks Outperform the "Magnificent Seven" in 2025?
151376988 D San : Resistance at 60. Yeah..nah she's going down.
Winner takes all OP 151376988 D San : be patients